A Vision of Future Treatment in Chagas Heart Disease
[...]to counteract the pathogenic potency of beta1-AABs, but presently only directed to beta1-AAB-positive patients with idiopathic dilated cardiomyopathy, new treatment strategies are under study that focus on beta1-AAB removal via an apheresis technique or drug treatment for in vivo beta1-AAB neut...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2014-03, Vol.63 (10), p.1027-1027 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [...]to counteract the pathogenic potency of beta1-AABs, but presently only directed to beta1-AAB-positive patients with idiopathic dilated cardiomyopathy, new treatment strategies are under study that focus on beta1-AAB removal via an apheresis technique or drug treatment for in vivo beta1-AAB neutralization (2). |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2013.08.1660 |